Pfizer seeks another ‘moonshot’ with $43 billion cancer deal

Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as the pharmaceutical giant remakes itself with financial windfall netted from its covid treatments.

Read the full post at Health
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive